Neupro transdermales Pflaster (2 mg/24 h, 6 mg/24 h und 8 mg/24 h), (parallel distribution EurimPharm Vertriebs-GmbH & Co. KG) New
Recall
|
Medicines
|
12/09/2025
The parallel distributor informed its customers on September 11, 2025, that the warning regarding impairment of the ability to drive and operate machinery is missing from the outer packaging of the mentioned batches. For this reason, the affected batches are being recalled.
| Name of the medicinal product | 1. Neupro 2 mg/24 h transdermales Pflaster 2. Neupro 6 mg/24 h transdermales Pflaster 3. Neupro 8 mg/24 h transdermales Pflaster |
|---|---|
| Marketing authorisation number(s) | 1. EU/1/05/331/002-P1 2. EU/1/05/331/008-P1 3. EU/1/05/331/011-P1 |
| CIP code | 1. 6061971 2. 6061994 3. 6062002 |
| Marketing authorisation holder | EurimPharm Vertriebs-GmbH & Co. KG |
| Batch number(s) | 1. 61912107 (repack batch number: 1000779127), expiry date: 31.01.2027 2. 60653133 (repack batch number: 1000779134), expiry date: 31.05.2026 3. 61901106 (repack batch number: 1000779135), expiry date: 30.09.2026 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-5318 |
Further inquiry note
Page last modified:
12/09/2025